Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the β3-adrenergic receptor gene

International Journal of Obesity

Volumn 27, Issue 9, 2003, Pages 1028-1036

  Shiwaku, K ^a   Nogi, A ^a   Anuurad, E ^a   Kitajima, K ^a   Enkhmaa, B ^a   Shimono, K ^a   Yamane, Y ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

3 adrenergic receptor; Education; Intervention; Mutation; Obesity; Weight loss

Indexed keywords

ARGININE; BETA 3 ADRENERGIC RECEPTOR; GENE PRODUCT; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LIPID; TRYPTOPHAN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BEHAVIOR MODIFICATION; BODY FAT; BODY MASS; BODY WEIGHT; CLIMACTERIUM; ENERGY EXPENDITURE; EXERCISE; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC POLYMORPHISM; GLUCOSE BLOOD LEVEL; HUMAN; JAPAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; PHENOTYPE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SKINFOLD; WEIGHT REDUCTION;

ADULT; AGED; BEHAVIOR THERAPY; BLOOD PRESSURE; BODY CONSTITUTION; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET; EXERCISE THERAPY; FEMALE; HUMANS; MIDDLE AGED; MUTATION; OBESITY; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-3; WEIGHT LOSS;

EID: 0041317780     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802375     Document Type: Article

References (45)

1. Public Health Service. The Surgeon General's report on nutrition and health. DHHS publication (PHS) 88-50210. US Department of Health and Human Services: Washington, DC; 1988.
2. Report of a WHO Consultation. Obesity: preventing and managing the global endemic. WHO Technical Report Series, No. 894. WHO: Geneva, 2000.
3. Curb JD, Marcus EB. Body fat and obesity in Japanese Americans. Am J Clin Nutr 1991; 53: 1552S-1555S.
4. Goto Y, Yamaguchi Y. Epidemiology of obesity. Nihon Rinsho 1993; 51(Supp 1): 247-257 (in Japanese).
5. Ohmura T, Ueda K, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Nomiyama K, Ohmori S, Yoshitake T, Shinkawa A, Hasuo Y, Fujishima M. Prevalence of type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: the Hisayama study. Diabetotogia 1993; 36: 1198-1203.
6. Tokunaga K, Matsuzawa Y, Kotani K, Keno Y, Kobatake T, Fujioka S, Tarui S. Ideal body weight estimated from the body mass index with the lowest morbidity. Int J Obes Relat Metab Disorder 1991; 15: 1-5.
7. Arner P. Hunting for human obesity genes? Look in the adipose tissue!. Int J Obes Relat Metab Disorder 2000; 24: S57-S62.
8. 3-adrenergic-receptor-gene. N Engl J Med 1995; 333: 343-347.
9. 3-adrenergic receptor gene with body mass index. J Clin Endocrinol Metab 1998; 83: 2441-2444.
10. Katzmarzyk P, Perusse L, Bouchard C. Genetics of abdominal visceral fat levels. Am J Hum Biol 1999; 11: 225-235.
11. Lofontan M, Berlan M. Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 1993; 34: 1057-1091.
12. 3-adrenoceptor? Trends Pharmacol Sci 1990; 11: 3-7.
13. 3-adrenergic receptor and an increase capacity to gain weight in patient with morbid obesity. N Engl J Med 1995; 333: 352-354.
14. 3-adrenergic-receptor-gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995; 333: 348-351.
15. Groop LC. Insulin resistance: the fundamental trigger of type 2 diabetes. Diabetes Obes Metab 1999; 1: S1-S7.
16. Luke A, Durazo-Arvizu R, Rotimi C, Prewitt TE, Ferrester T, Wilks R, Ogunbiyi OJ, Schoeller DA, McGee D, Cooper RS. Relation between body mass index and body fat in black population samples from Nigeria, Jamaica, and the United States. Am J Epidemiol 1997; 145: 620-628.
17. 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 1995; 215: 555-560.
18. 3-adrenergic receptor of obesity. Lancet 1995; 246: 1433-1434.
19. 3-adrenergic receptor gene has no effect on obesity phenotypes in the Quebec Family Study and Swedish Obese Subjects Cohorts. J Clin Invest 1996; 98: 2086-2093.
20. 3-adrenergic receptor in Japanese NIDDM patients. Diabetic Care 1996; 19: 271-272.
21. 3-adrenergic receptor gene in Japanese subjects. Metabolism 1997; 46: 199-202.
22. 3-adrenergic receptor gene polymorphism in Japanese: meta-analysis. Obes Res 2001; 9: 741-745.
23. 3-adrenergic receptor with body mass index. Int J Obes Relat Metab Disord 1998; 22: 559-566.
24. 3-adrenergic receptor gene is not associated with moderate overweight in Japanese workers. Metabolism 1998; 47: 1528-1530.
25. The National Heart Lung and Blood Institute Obesity Education Initiative Expert Panel. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. National Institute of Health Publication No. 98-4083. NIH: Bethesda, 1998.
26. National Institute of Health Technology Assessment Conference Panel. Methods for voluntary weight loss and control. Anal Intern Med 1992; 116: 942-949.
27. Latner LD. Self-help in the long-term treatment of obesity. Obes Rev 2001; 2: 87-97.
28. Wing RR, Sallis Jr J, Goldstein GM, Smith-West D, Action JK, Jeffery WB, Birch LL, Surwit SR, Jakicic MJ. Behavioral science research in diabetes. Diabetes Care 2001; 24: 117-123.
29. Morimoto A, Takase Y, Hada K, Hosoya N. Evaluation of a 'convenient method' for the estimation dietary food consumption. Jpn J Nutr 1977; 35: 235-245. (in Japanese).
30. Resources Council, Science and Technology Agency, Standard tables of food composition in Japan, 5th revised edn. Printing Bureau, Ministry Finance, Tokyo (in Japanese).
31. Utter AC, Nieman DC, Ward AN, Butterworth DE. Use of the leg-to-leg bioelectrical impedance method in assessing body-composition change in obese women. Am J Clin Nutr 1999; 69: 603-607.
32. Stevens-Simon C, Thureen P, Barrett J, Stamm E. Skinfold caliper and ultrasound assessments of change in the distribution of subcutaneous fat during adolescent pregnancy. Int J Obes Relat Metab Disord 2001; 25: 1340-1345.
33. Nagamine S. Standard of obesity. Jpn J Med Assoc 1972; 68: 916-932. (in Japanese).
34. VINE Corp. The instruction manual of nondispersive infrared analysis. VINE Corp: Tokyo; 2000 (in Japanese).
35. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
36. Jequier E, Tappy L. Regulation of body weight in humans. Physiol Rev 1999; 79: 461-480.
37. 3-adrenoceptor gene variant. Diabetes 2000; 9: 1709-1713.
38. 3-adrenergic receptor and insulin receptor substrate 1 in relation to weight loss, waist to hip ratio and frequencies of common cardiovascular risk factors. Exp Clin Endocrinol Diabetes 2000; 108: 86-92.
39. 3-adrenergic receptor gene affect basal metabolic rate in obese Finns. Diabetes 1997; 46: 77-80.
40. 3-adrenoceptor gene variant in postmenopausal women. Diabetes 1999; 48: 1425-1428.
41. 3-adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women; effects of weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population. Diabetes 1996; 45: 1358-1363.
42. Kaplan MN. The deadly quartet, upper-body, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989; 149: 1514-1520.
43. 3-adrenergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome. Int J Obes Relat Metab Disord 2000; 24: 545-551.
44. Kushner RF, Kunigk A, Alspaugh M, Andronis PT, Leitch CA, Schoeller DA. Validation of bioelectrical-impedance analysis as a measure of change in body composition in obesity. Am J Clin Nutr 1990; 52: 219-223.
45. Lukaski HC. Requirements for clinical use of bioelectrical impedance analysis (BIA). Ann NY Acad Sci 1999; 873: 72-76.